Business Model
YM BioSciences is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development. |
|
|
Nimotuzumab
An anti-cancer antibody that targets the epidermal growth factor receptor, with an improved side-effect profile compared to marketed EGFR-targeting products. |
|
AeroLEF®
A proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. |
|
|
